Effects of radix glycyrrhiza and its main components on the function and expression of P-glycoprotein in Caco-2 cells

Chinese Pharmaceutical Journal

Volumn 45, Issue 10, 2010, Pages 751-755

  He, Dan ^a,b   Yan, Miao ^a   Li, Huan De ^a   Liu, Feng Qin ^b   Yu, De Ya ^b   Yang, Chang Cheng ^b   Xu, Dan Hua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b No 163 Central Hospital of PLA   (China)

Author keywords

Caco 2 cells; Glycyrrchizin; Glycyrrhetinic acid; Liquiritin; P glycoprotein; Radix glycyrrhiza

Indexed keywords

FLAVONOID; GLYCOPROTEIN P; GLYCYRRCHIZIN; GLYCYRRHETINIC ACID; LIQUIRITIN; RHODAMINE 123; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN CACO 2; DRUG EFFECT; FLOW CYTOMETRY; GLYCYRRHIZA; INCUBATION TIME; MEDICINAL PLANT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIX GLYCYRRHIZA; UPREGULATION;

EID: 77956535880     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. SHAROM F J. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1)[J]. Biochem Cell Biol, 2006, 84(6): 979-992.
2. MAGGIO-PRICE L, SHOWS D, WAGGIE K, et al. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice[J]. Am J Pathol, 2002, 160(2): 739-751.
3. VAN DER SANDT I C, GAILLARD P J, VOORWINDEN H H, et al. P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier[J]. Pharm Res, 2001, 18(5): 587-592.
4. ABU-QARE A W, ELMASRY E, ABOU-DONIA M B. A role for P-glycoprotein in environmental toxicology[J]. J Toxicol Environ Health B Crit Rev, 2003, 6(3): 279-288.
5. PAOLINI M, POZZETTI L, SAPONE A, et al. Effect of licorice and glycyrrhizin on murine liver CYP-dependent monooxygenases[J]. Life Sci, 1998, 62(6): 571-582.
6. YANG J, PENG R X, KONG R, et al. Effects of 18 alpha-glycyrrhizic acid on rat liver cytochrome P450 isoenzymes and phase II transferase[J]. Acta Pharm Sin, 2001, 36(5): 321-324.
7. PAULI-MAGNUS C, VON RICHTER O, BURK O, et al. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein[J]. J Pharmacol Exp Ther, 2000, 293(2): 376-382.
8. GRANZOTTO M, DRIGO I, CANDUSSIO L, et al. Rifampicin and verapamil induce the expression of P-glycoprotein in vivo in Ehrlich ascites tumor cells[J]. Cancer Lett, 2004, 205(1): 107-115.
9. TAKARA K, HORIBE S, OBATA Y, et al. Effects of 19 herbal extracts on the sensitivity to paclitaxel or 5-fluorouracil in HeLa cells[J]. Biol Pharm Bull, 2005, 28(1): 138-142.
10. TAKEDA S, ISHTHARA K, WAKUI Y, et al. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats: relevance to the intestinal bacterial hydrolysis[J]. J Pharm Pharmacol, 1996, 48(9): 902-905.
11. HOCHMAN J H, CHIBA M, YAMAZAKI M, et al. P-glycoprotein-mediated efflux of indinavir metabolites in Caco-2 cells expressing cytochrome P4503A4[J]. J Pharmacol Exp Ther, 2001, 298(1): 323-330.